Biomarker Trial Landscape Development Status Summary Table Commercial Information Involved Organisations Credit Suisse Market Status Credit Suisse Financial Forecast Scientific Summary Adverse events Therapeutic trials Future Events Development History References X...
Telavant, a Roivant company, is developing innovative therapies to help patients living with inflammatory and fibrotic diseases. Telavant is developing RVT-3101 as a potential best-in-class and first-in...